Close

Form SC 13G Third Harmonic Bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P. Nov 27, 2023 04:30PM
Arvinas Inc. (ARVN) Announces Oversubscribed $350M Share and Warrant Placement at $21.36/sh Nov 27, 2023 07:01AM
Form SC 13D/A Eliem Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P. Nov 17, 2023 04:31PM
Form 13F-HR/A RA CAPITAL MANAGEMENT, For: Sep 30 Nov 15, 2023 08:13AM
LENZ Therapeutics and Graphite Bio (GRPH) Announce Merger Agreement Nov 15, 2023 07:01AM
View Older Stories

Nov 14, 2023 07:30PM Form SC 13G/A Design Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 14, 2023 07:17PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Sep 30
Nov 6, 2023 04:31PM Form SC 13G Harpoon Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Oct 30, 2023 04:46PM Form SC 13G MACROGENICS INC Filed by: RA CAPITAL MANAGEMENT, L.P.
Oct 23, 2023 07:18AM Harpoon Therapeutics Inc. (HARP) Announces Up to $150 Million Private Placement
Oct 5, 2023 05:09PM Form SC 13G SOLENO THERAPEUTICS INC Filed by: RA CAPITAL MANAGEMENT, L.P.
Oct 5, 2023 04:44AM Orchard Therapeutics (ORTX) Acquired by Kyowa Kirin for $16/sh Cash plus $1 CVR
Oct 2, 2023 07:31AM SAB Biotherapeutics (SABS) Announces Private Placement of up to $130 Million
Sep 29, 2023 05:01PM Form SC 13G CHIMERIX INC Filed by: RA CAPITAL MANAGEMENT, L.P.
Sep 25, 2023 04:31PM Form SC 13D/A ARS Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.
Sep 22, 2023 04:30PM Form SC 13G CymaBay Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Sep 19, 2023 05:25PM Form SC 13D/A Cytek Biosciences, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 31, 2023 05:26PM Form SC 13D ARS Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 29, 2023 09:01AM Inhibrx Inc. (INBX) Announces $200M Financing at $19.35/sh
Aug 25, 2023 05:02PM Form SC 13G Taysha Gene Therapies, Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 21, 2023 04:31PM Form SC 13G Gracell Biotechnologies Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 17, 2023 04:30PM Form SC 13G NEKTAR THERAPEUTICS Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 14, 2023 05:02PM Form SC 13G/A BELLUS Health Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 14, 2023 05:00PM Form SC 13G/A Kinnate Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 14, 2023 04:31PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Jun 30
Aug 14, 2023 07:02AM Taysha Gene Therapies (TSHA) Reports Initial Clinical Data from First Adult Rett Syndrome Patient Dosed in REVEAL Phase 1/2 Trial
Aug 14, 2023 07:00AM Taysha Gene Therapies (TSHA) Announces $150M Financing
Aug 11, 2023 05:06PM Form SC 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 11, 2023 05:02PM Form SC 13D/A 89bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 9, 2023 05:00PM Form SC 13D/A DICE Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 7, 2023 07:48AM Gracell Biotechnologies (GRCL) Announces Up to $150 Million Private Placement Financing Joined by a Syndicate of Premier Healthcare Investors
Aug 1, 2023 04:31PM Form SC 13G/A NewAmsterdam Pharma Co Filed by: RA CAPITAL MANAGEMENT, L.P.
Jul 27, 2023 09:55AM UroGen Pharma (URGN) Announces $120 Million Private Placement of Ordinary Shares
Jul 25, 2023 04:32PM Form SC 13D/A Acumen Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.
Jul 11, 2023 05:00PM Aerovate Therapeutics (AVTE) Appoints Habib Dable To Its Board
Jul 6, 2023 04:33PM Form SC 13G Talaris Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Jul 6, 2023 04:31PM Form SC 13G Unicycive Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Jun 27, 2023 05:01PM Form SC 13D/A Aerovate Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Jun 26, 2023 07:08AM Orchard Therapeutics (ORTX) Announces Second Closing of Strategic Financing, Resulting in $34 Million of Additional Capital
Jun 22, 2023 08:22AM Aeglea BioTherapeutics (AGLE) Acquires Spyre Therapeutics
Jun 22, 2023 07:31AM Talaris Therapeutics (TALS) and Tourmaline Bio Announce Merger Agreement
Jun 21, 2023 05:01PM Form SC 13D/A DICE Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Jun 12, 2023 05:01PM Form SC 13D/A Satsuma Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.
Jun 5, 2023 04:32PM Form SC 13G 4D Molecular Therapeutic Filed by: RA CAPITAL MANAGEMENT, L.P.
May 30, 2023 05:01PM Form SC 13D/A Icosavax, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
May 15, 2023 05:02PM Form SC 13G/A Travere Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
May 15, 2023 05:02PM Form SC 13G/A DA32 Life Science Tech Filed by: RA CAPITAL MANAGEMENT, L.P.
May 15, 2023 05:02PM Form SC 13G/A ARYA Sciences Acquisitio Filed by: RA CAPITAL MANAGEMENT, L.P.
May 15, 2023 04:18PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Mar 31
Apr 18, 2023 04:30PM Form SC 13D/A Satsuma Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 10, 2023 05:05PM Form SC 13G NanoString Technologies Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 10, 2023 05:02PM Form SC 13D/A Eliem Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 10, 2023 05:01PM Form SC 13G/A Ascendis Pharma A/S Filed by: RA CAPITAL MANAGEMENT, L.P.
Mar 30, 2023 05:09PM Form SC 13G/A GH Research PLC Filed by: RA CAPITAL MANAGEMENT, L.P.
Mar 30, 2023 05:07PM Form SC 13D/A Acrivon Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
View Older Stories